Walter Strapps
Director/Board Member at SONA NANOTECH INC.
Net worth: - $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Lievonen | M | - | 4 years | |
| Darren Rowles | M | 45 | 6 years | |
| Neil Fraser | M | - | 2 years | |
| Jim Megann Megann | M | 59 | 5 years | |
| Rob Randall | M | 61 | 6 years | |
| Kulbir Singh | M | - | 20 years | |
| Michael McAlduff | M | - | 20 years | |
| Cameron Myhrvold | M | - |
Carver Biosciences, Inc.
 Carver Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Carver Biosciences, Inc. is a gene therapy company based in Dedham, MA. Carver is developing CRISPR-based therapies for RNA viruses that infect humans, using a programmable platform technology that could offer a generalizable solution for treating many viruses. The company's underlying technology was developed by co-founder Dr. Cameron Myhrvold. Carver Biosciences is leveraging Cas13 to target respiratory viruses at the RNA level, with the aim of destroying the viruses and preventing them from replicating. The company's therapeutics would act in concert with Dr. Uri Lopatin. The company was founded by Cameron Myhrvold and Walter Strapps, with Walter Strapps serving as the CEO since incorporation. | 3 years |
| Leonard Pagliaro | M | - | 1 years | |
| David Regan | M | 55 | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Gross | M | - | 5 years | |
| Daniel Whittaker | M | 65 | 4 years | |
| Robert McKay | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 12 | 92.31% |
| United States | 1 | 7.69% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Walter Strapps
- Personal Network
